title: Cutaneous leishmaniasis with pseudoepitheliomatous hyperplasia simulating squamous cell carcinoma.
authors.forename: Leonardo Pereira
authors.initials: LP
authors.lastname: Quintella
authors.forename: Tullia
authors.initials: T
authors.lastname: Cuzzi
authors.forename: Maria
authors.initials: M
authors.lastname: de Fátima Madeira
authors.forename: Cláudia Maria
authors.initials: CM
authors.lastname: Valete-Rosalino
authors.forename: Mariza
authors.initials: M
authors.lastname: de Matos Salgueiro
authors.forename: Erica
authors.initials: E
authors.lastname: de Camargo Ferreira e Vasconcellos
authors.forename: Eliame
authors.initials: E
authors.lastname: Mouta-Confort
authors.forename: Sonia Regina
authors.initials: SR
authors.lastname: Lambert Passos
authors.forename: Armando
authors.initials: A
authors.lastname: de Oliveira Schubach
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis*; D003937:Diagnosis, Differential; D004847:Epithelial Cells / Q000473:pathology*; D006801:Humans; D006965:Hyperplasia; D007892:Leishmania braziliensis / Q000166:cytology / Q000254:growth & development / Q000302:isolation & purification; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D008875:Middle Aged; D009942:Organometallic Compounds / Q000627:therapeutic use
chemical_list: D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate